Structure Therapeutics Inc.
GPCR
$54.51
-$0.19-0.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -106.16M | -75.97M | 33.00M | -65.71M | -61.66M |
| Total Depreciation and Amortization | 570.00K | 586.00K | 734.00K | 379.00K | 291.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.99M | 9.03M | -4.32M | 4.83M | 3.73M |
| Change in Net Operating Assets | -24.51M | 81.58M | -93.83M | 9.51M | 3.08M |
| Cash from Operations | -120.12M | 15.23M | -64.42M | -51.00M | -54.56M |
| Capital Expenditure | 42.00K | -1.18M | -1.50M | -1.57M | -232.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 5.09M | 5.16M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 74.46M | -495.77M | 52.55M | -52.91M | 49.17M |
| Cash from Investing | 74.50M | -496.95M | 56.14M | -49.32M | 48.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.09M | 869.00K | 706.24M | 57.44M | 517.00K |
| Repurchase of Common Stock | 0.00 | -2.57M | 0.00 | -462.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -37.00K | -1.25M | -770.00K | -- |
| Cash from Financing | 2.09M | -1.74M | 704.99M | 56.20M | 517.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.53M | -483.46M | 696.71M | -44.11M | -5.10M |